DekaBank Deutsche Girozentrale
LXRX icon

DekaBank Deutsche Girozentrale’s Lexicon Pharmaceuticals LXRX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-76,282
Closed -$465K – 1072
2019
Q2 		$465K Sell
76,282
-32,159
-30% -$193K ﹤0.01% 930
2019
Q1 		$1.27M Buy
108,441
+26,022
+32% +$158K 0.01% 711
2018
Q4 		$528K Sell
82,419
-26,022
-24% -$211K ﹤0.01% 819
2018
Q3 		$1.27M Sell
108,441
-1,000
-0.9% -$11.5K 0.01% 723
2018
Q2 		$1.36M Buy
109,441
+2,000
+2% +$20.5K 0.01% 679
2018
Q1 		$899K Sell
107,441
-36,000
-25% -$333K 0.01% 745
2017
Q4 		$2.08M Hold
143,441
– – 0.02% 536
2017
Q3 		$2.08M Hold
143,441
– – 0.02% 544
2017
Q2 		$2.37M Buy
+143,441
New +$2.22M 0.02% 514
2016
Q3 		– Sell
-51,741
Closed -$735K – 998
2016
Q2 		$735K Buy
51,741
+7,100
+16% +$96.3K 0.01% 596
2016
Q1 		$549K Sell
44,641
-8,100
-15% -$84.9K 0.01% 638
2015
Q4 		$705K Buy
52,741
+600
+1% +$7.38K 0.01% 625
2015
Q3 		$560K Buy
52,141
+1,300
+3% +$14.2K 0.01% 672
2015
Q2 		$409K Buy
50,841
+2,355
+5% +$17.3K ﹤0.01% 739
2015
Q1 		$320K Buy
48,486
+9,072
+23% +$61.9K ﹤0.01% 813
2014
Q4 		$239K Sell
39,414
-3,643
-8% -$29.4K ﹤0.01% 827
2014
Q3 		$425K Buy
43,057
+857
+2% +$9.15K 0.01% 693
2014
Q2 		$476K Sell
42,200
-2,429
-5% -$26.1K 0.01% 604
2014
Q1 		$540K Buy
44,629
+2,858
+7% +$36.5K 0.01% 564
2013
Q4 		$529K Buy
41,771
+857
+2% +$13.6K 0.01% 535
2013
Q3 		$682K Buy
+40,914
New +$686K 0.01% 503

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DekaBank Deutsche Girozentrale's LXRX Position: Q3 2019 in Review

DekaBank Deutsche Girozentrale sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2019, closing a stake of 76,282 shares — an estimated $465K sold.

DekaBank Deutsche Girozentrale first reported a position in LXRX in Q3 2013 and held it in 21 quarters. The position peaked at $2.37M in Q2 2017. 103 funds tracked by Wall St. Rank hold LXRX as of Q3 2019.

  • DekaBank Deutsche Girozentrale reported no remaining Lexicon Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 76,282 Lexicon Pharmaceuticals shares in Q3 2019, an estimated $465K.
  • DekaBank Deutsche Girozentrale first reported a position in Lexicon Pharmaceuticals in Q3 2013 and held it in 21 quarters.
  • DekaBank Deutsche Girozentrale's Lexicon Pharmaceuticals position peaked at $2.37M in Q2 2017.
  • 103 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2019.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2019, filed 14 Nov 2019.